Vesti

• NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
  08.03.2022 / 08:00 - GlobeNewswire
•  
• Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional Deep Brain Stimulation System
  17.06.2021 / 09:00 - GlobeNewswire
•  
• Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report
  15.04.2021 / 12:52 - TeleTrader
•  
• EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4
  14.04.2021 / 13:52 - TeleTrader
•  
• Pfizer, BioNTech grant EU 200 million vaccine doses
  11.11.2020 / 12:30 - TeleTrader
•  
• Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raises USD 8 Million Private Equity
  16.12.2019 / 09:55 - GlobeNewswire
•  
• Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS, SNS, VNS and Other CNS
  19.10.2018 / 11:00 - GlobeNewswire
•  
• Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
  02.01.2018 / 14:05 - GlobeNewswire
•  
• Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
  06.12.2017 / 16:23 - GlobeNewswire
•  
• Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
  19.10.2017 / 15:00 - GlobeNewswire
•  
• Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP 150 million
  02.12.2016 / 07:30 - GlobeNewswire
•  
• Biotech stocks continue to advance
  21.10.2016 / 07:00 - GlobeNewswire
•  
• BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
  11.10.2016 / 18:10 - GlobeNewswire
•  
• Ad hoc: BB Biotech AG with profit in the third quarter 2016
  11.10.2016 / 18:09 - GlobeNewswire
•  
• Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management to new high of close to CHF 7 bn
  29.07.2016 / 07:00 - GlobeNewswire